PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer |
Wang, Yitao
(Department of Biochemistry and Molecular Biology, Chongqing Medical University)
Zhang, Chunxue (Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Sichuan University) Mai, Li (Department of Clinical Laboratory, The Second Affiliated Hospital, Chongqing Medical University) Niu, Yulong (Department of Biochemistry and Molecular Biology, Chongqing Medical University) Wang, Yingxiong (Laboratory of Reproductive Biology, School of Public Health, Chongqing Medical University) Bu, Youquan (Department of Biochemistry and Molecular Biology, Chongqing Medical University) |
1 | Lehmann BD and Pietenpol JA (2012) Targeting mutant p53 in human tumors. J Clin Oncol Off J Am Soc Clin Oncol 30, 3648-3650 DOI |
2 | Nguyen D, Liao W, Zeng SX and Lu H (2017) Reviving the guardian of the genome: Small molecule activators of p53. Pharmacol Ther 178, 92-108 DOI |
3 | Miller L, Smeds J, George JD et al (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102, 13550-13555 DOI |
4 | Gyorffy B, Lanczky A, Eklund AC et al (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat 123, 725-731 DOI |
5 | Chaudhary S, Madhukrishna B, Adhya AK, Keshari S and Mishra SK (2016) Overexpression of caspase 7 is ERalpha dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis 5, e219 DOI |
6 | Murphy CG and Dickler MN (2015) The Role of CDK4/6 inhibition in breast cancer. Oncologist 20, 483-490 DOI |
7 | Wang L, Zhan X, Shen X et al (2018) P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. Mol Cell Biochem 446, 137-148 DOI |
8 | Selander KS, Li L, Watson L et al (2004) Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy. Cancer Res 64, 6924-6933 DOI |
9 | Niki T, Izumi S, Saegusa Y et al (2000) MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc. Genes Cells Devoted Mol Cell Mech 5, 127-141 DOI |
10 | Rice L, Waters CE, Eccles J et al (2008) Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J Endocrinol 198, 499-509 DOI |
11 | Lange AM and Lo H-W (2018) Inhibiting TRK Proteins in clinical cancer therapy Cancers 10, 105 DOI |
12 | Chan YW, Jeyaprakash AA, Nigg EA and Santamaria A (2012) Aurora B controls kinetochore-microtubule attachments by inhibiting Ska complex-KMN network interaction. J Cell Biol 196, 563-571 DOI |
13 | Siegel RL, Miller KD and Jemal A (2018) Cancer statistics, 2018: Cancer Statistics, 2018. CA Cancer J Clin 68, 7-30 DOI |
14 | Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015: Cancer Statistics in China, 2015. CA Cancer J Clin 66, 115-132 DOI |
15 | Trinklein ND (2003) An Abundance of Bidirectional Promoters in the Human Genome. Genome Res 14 62-66 DOI |
16 | Ji Y, Xie M, Lan H et al (2013) PRR11 is a novel gene implicated in cell cycle progression and lung cancer. Int J Biochem Cell Biol 45, 645-656 DOI |
17 | Song Z, Liu W, Xiao Y et al (2015) PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer. PLoS One 10, e0128943 DOI |
18 | Chen Y, Cha Z, Fang W et al (2015) The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma. Oncotarget 6, 20419-20433 DOI |
19 | Zhang C, Zhang Y, Li Y et al (2015) PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC). Biochem Biophys Res Commun 458, 501-508 DOI |
20 | Guimaraes GJ and DeLuca JG (2009) Connecting with Ska, a key complex at the kinetochore-microtubule interface. EMBO J 28, 1375-1377 DOI |
21 | Gaitanos TN, Santamaria A, Jeyaprakash AA, Wang B, Conti E, Nigg EA (2009) Stable kinetochore-microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3. EMBO J 28, 1442-1452 DOI |
22 | Zhang Q, Sivakumar S, Chen Y et al (2017) Ska3 Phosphorylated by Cdk1 Binds Ndc80 and Recruits Ska to Kinetochores to Promote Mitotic Progression. Curr Biol 27, 1477-1484.e4 DOI |
23 | Jeyaprakash AA, Santamaria A, Jayachandran U et al (2012) Structural and functional organization of the Ska complex, a key component of the kinetochore-microtubule interface. Mol Cell 46, 274-286 DOI |
24 | Welburn JPI, Grishchuk EL, Backer CB et al (2009) The human kinetochore Ska1 complex facilitates microtubule depolymerization-coupled motility. Dev Cell 16, 374-385 DOI |
25 | Hanisch A, Sillje HH, and Nigg EA (2006) Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. EMBO J 25, 5504-5515 DOI |
26 | Zhang L (2018) Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells. Genes Dis 5, 158-166 DOI |
27 | Wang Y, Zhang Y, Zhang C et al (2015) The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development. Biochim Biophys Acta BBA - Gene Regul Mech 1849, 1133-1144 DOI |
28 | Wang Y, Weng H, Zhang Y et al (2017) The PRR11-SKA2 bidirectional transcription unit is negatively regulated by p53 through NF-Y in lung cancer cells. Int J Mol Sci 18, 534 DOI |